3-Chloro-5-hydroxybenzoic acid structure
|
Common Name | 3-Chloro-5-hydroxybenzoic acid | ||
---|---|---|---|---|
CAS Number | 53984-36-4 | Molecular Weight | 172.566 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 364.8±27.0 °C at 760 mmHg | |
Molecular Formula | C7H5ClO3 | Melting Point | N/A | |
MSDS | Chinese USA | Flash Point | 174.4±23.7 °C | |
Symbol |
GHS05, GHS07 |
Signal Word | Danger |
Use of 3-Chloro-5-hydroxybenzoic acid3-Chloro-5-hydroxybenzoic acid is a potent, orally active and selective lactate receptor GPR81 agonist, with an EC50 of 16 μM for human GPR81. 3-Chloro-5-hydroxybenzoic acid exhibits favorable in vivo effects on lipolysis in a mouse model of obesity[1]. |
Name | 3-Chloro-5-hydroxybenzoic acid |
---|---|
Synonym | More Synonyms |
Description | 3-Chloro-5-hydroxybenzoic acid is a potent, orally active and selective lactate receptor GPR81 agonist, with an EC50 of 16 μM for human GPR81. 3-Chloro-5-hydroxybenzoic acid exhibits favorable in vivo effects on lipolysis in a mouse model of obesity[1]. |
---|---|
Related Catalog | |
In Vitro | 3-Chloro-5-hydroxybenzoic acid shows potency against human (EC50=16 μM), monkey (EC50=17 μM), dog (EC50=67 μM), rat (EC50=7 μM), mouse (EC50=22 μM), and hamster GPR81 (EC50=27 μM)[1]. |
In Vivo | 3-Chloro-5-hydroxybenzoic acid (30, 100, and 300 mg/kg; PO in overnight fasted C57Bl6/J mice fed high fat chow for 10 weeks) shows significant reductions in free fatty acids at all doses tested, resulting in a minimum efficacious dose of 30 mg/kg[1]. Pharmacokinetic Parameters of 3-Chloro-5-hydroxybenzoic acid in Mice[1]. dose (mg/kg) tmax (h) AUCinf (h ng/mL) Cmax (ng/mL) Cmax (μM) t1/2 (h) 30 0.5 9356 11689.50 67.2 1.47 100 0.5 51312 55252.80 341.9 1.10 Animal Model: C57Bl6/J mice (DIO mice)[1] Dosage: 30, 100, and 300 mg/kg Administration: PO in overnight fasted C57Bl6/J mice fed high fat chow for 10 weeks Result: Significant reductions in nonesterified free fatty acid cholesterol (NEFAc) at all doses tested. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 364.8±27.0 °C at 760 mmHg |
Molecular Formula | C7H5ClO3 |
Molecular Weight | 172.566 |
Flash Point | 174.4±23.7 °C |
Exact Mass | 171.992722 |
PSA | 57.53000 |
LogP | 2.83 |
Vapour Pressure | 0.0±0.9 mmHg at 25°C |
Index of Refraction | 1.630 |
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H302-H315-H318-H335 |
Precautionary Statements | P261-P280-P305 + P351 + P338 |
RIDADR | NONH for all modes of transport |
HS Code | 2918290000 |
~80% 3-Chloro-5-hydr... CAS#:53984-36-4 |
Literature: ASTRAZENECA AB Patent: WO2003/101956 A1, 2003 ; Location in patent: Page 55; 56 ; WO 03/101956 A1 |
Precursor 1 | |
---|---|
DownStream 1 | |
HS Code | 2918290000 |
---|---|
Summary | HS: 2918290000 other carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) VAT:17.0% MFN tariff:6.5% General tariff:30.0% |
Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity.
Gastroenterology 146(7) , 1763-74, (2014) The NACHT, LRR, and pyrin domain-containing protein 3 (NLRP3) inflammasome induces inflammation in response to organ injury, but little is known about its regulation. Toll-like receptors (TLRs) provid... |
Benzoic acid, 3-chloro-5-hydroxy- |
3-Chloro-5-hydroxybenzoic acid |